Home
Our Company
Our Story
Our Leadership
Our Impacts
Our Science
Pipeline
Disease Area
Mechanism of Action
Media
Press Releases
Investors
Our Investors
Contact Us
General Enquiries
Follow Us
Media
Press Releases
Shanton Pharma Raised $31.2 Million in Series A+ Financing
Feb 09, 2021
Shanton Pharma Meets Primary Endpoint for Phase 2 Study of SAP-001
Feb 09, 2021